Veradigm Inc (MDRX, Financial), a company trading on the U.S. OTC market, experienced a significant stock price drop of 5%. The stock is currently priced at $7.60 per share with a trading volume of 1,496 shares. Recent financial reports indicate that Veradigm Inc generated $152 million in revenue, with a net profit of $10.93 million and earnings per share of $0.08. The company's gross profit was $78.22 million, resulting in a price-to-earnings ratio of 18.90.
In terms of analyst recommendations, 25% of the four participating institutions rated the stock as a buy, while 75% suggested holding, with no sell recommendations. The health information services industry, where Veradigm operates, saw an overall decline of 0.36%. Despite this, some related stocks like Genedx Holdings Corp and Vsee Health Inc showed significant gains, while others like Aclarion, Inc. and Foxo Technologies Inc. remained active with higher turnover rates.
Veradigm Inc is a healthcare technology company that leverages its platform, data, and expertise to deliver clinical and financial solutions at the point of care. The company is known for its innovative solutions and partnerships that aim to transform the healthcare industry.
